BortePlus 2mg Injection

Bortezomib (2mg) Primary uses of : Multiple myeloma, Mantle-cell lymphoma
Manufacturer: Alkem Laboratories Ltd
*
₹ 6,560.00 incl tax
Expert advice for BortePlus Injection Before taking bortezomib, consult your doctor if you have any of the following disease conditions: disease of liver, kidney, heart or infections like fever with rash or genital sores, diabetes, low number of red or white blood cells or bleeding problems.Drink plenty of fluids every day during your treatment with bortezomib.Tell your doctor if you are or planning to become pregnant or are breastfeeding.Consult your doctor if you have signs of serious brain infection such as memory loss, trouble in thinking, difficulty with walking or loss of vision.Do not drive or operate machinery after taking bortezomib as it may cause tiredness, dizziness, fainting or blurred vision.
Composition Bortezomib (2mg)
Potentially Unsafe With Lactation
Side Effect Common Low blood platelets, Fatigue, Peripheral neuropathy (tingling and numbness of feet and hand), Psychiatric disturbances, Nausea, Vomiting, Loss of appetite, Fever, Anemia (low number of red blood cells), Diarrhoea, Decreased appetite, Decreased white blood cell count (neutrophils), Constipation.
How to works How BortePlus Injection works BortePlus 2mg Injection is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in a number of proteins in the cancer cells leading to their death.